Cargando…
Risk factors associated with bloodstream infections among critically ill patients with COVID-19
Autores principales: | McMillan, Tim, Jones, Conor, O'Connor, Cavan J, Nolan, Daniel, Chan, Xin Hui S, Ellis, Jayne, Thakker, Clare, Kranzer, Katharina, Stone, Neil RH, Singer, Mervyn, Wilson, A Peter R, Arulkumaran, Nishkantha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444445/ https://www.ncbi.nlm.nih.gov/pubmed/34537320 http://dx.doi.org/10.1016/j.jinf.2021.09.010 |
Ejemplares similares
-
The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19
por: Zacharias, Harry, et al.
Publicado: (2022) -
Immunomodulators in COVID-19: Two Sides to Every Coin
por: Snow, Timothy A. C., et al.
Publicado: (2020) -
Use of non-invasive ventilation for patients with COVID-19: a cause for concern?
por: Arulkumaran, Nishkantha, et al.
Publicado: (2020) -
Creating complex protocells and prototissues using simple DNA building blocks
por: Arulkumaran, Nishkantha, et al.
Publicado: (2023) -
Is the inflammasome a potential therapeutic target in renal disease?
por: Turner, Clare M, et al.
Publicado: (2014)